[Long-term progression-free survival after reduction surgery and postoperative low-dose imatinib administration for multiple liver metastases of duodenal gastrointestinal stromal tumor].

Nishitai, Ryuta; Manaka, Dai; Uehara, Masahiro; Hamasu, Shinya; Konishi, Sayuri; Sakamoto, Katsunori; Yoshino, Kenji; Kanto, Satoshi; Yokoyama, Daiju; Kobayashi, Aki; Jinzai, Yuki; Yasuhara, Yumiko

Nishitai, Ryuta; Manaka, Dai; Uehara, Masahiro; Hamasu, Shinya; Konishi, Sayuri; Sakamoto, Katsunori; Yoshino, Kenji; Kanto, Satoshi; Yokoyama, Daiju; Kobayashi, Aki; Jinzai, Yuki; Yasuhara, Yumiko.

Affiliation

Nishitai R; Dept. of Surgery, Digestive Disease Center, Kyoto Katsura Hospital.

Gan To Kagaku Ryoho ; 39(6): 979-82, 2012 Jun.

Article in Ja | MEDLINE | ID: mdl-22705697

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Gastrointestinal Stromal Tumors / Duodenal Neoplasms / Liver Neoplasms / Antineoplastic Agents Limits: Female / Humans / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 2012 Document type: Article Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links